It was found that berberine and silymarin could improve the level of blood lipid and fasting blood glucose

Recently, published in the Journal of Phytotherapy Research, researchers from the University of Bologna, the University of L'Aquila and the University of Palermo, Italy, conducted a meta-analysis of five randomized, double-blind, placebo-controlled clinical trials (http:// (RCTs) (http:// and found that formula containing berberine and silymarin The product (http:// can improve the level of blood lipid and fasting blood glucose The report shows that the blood glucose level of the subjects decreased significantly, with an average of 7.5 mg / dl Berberine is well known for its lipid-lowering effect in humans, and the researchers clearly confirmed it through a meta-analysis of 27 clinical studies involving 2569 participants Compared with meta-analysis, the results showed that increasing silymarin (berberine) could have a positive effect on human lipid and glucose metabolism, allowing the use of lower doses (berberine), thereby reducing the risk of gastrointestinal discomfort associated with a significant dose A systematic review of the literature by Italian scientists found that five eligible RCTs were included in their meta-analysis The data came from 497 people The study time ranged from 3 to 12 months, with berberine at 500 or 1000 mg / day and silymarin at 105 or 210 mg / day The results showed that the total cholesterol decreased 25 mg / dl, triglyceride 28 mg / dl, LDL cholesterol 29 mg / dl and HDL cholesterol increased 6 mg / dl The existing research results show that the combination of berberine and silymarin can improve blood lipid and blood glucose levels, which may be used to promote the metabolic health of the heart (http://